Jia-an Hu

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Hsa_circ_0003288 facilitates tumor progression by targeting miR-145 in non-small cell lung cancer cells.

Hsa_circ_0003288 facilitates tumor progression by targeting miR-145 in non-small cell lung cancer cells.

Journal: Cancer biomarkers : section A of Disease markers

Published: January 10, 2022

KRAS G12V mutation upregulates PD-L1 expression via TGF-β/EMT signaling pathway in human non-small-cell lung cancer.

KRAS G12V mutation upregulates PD-L1 expression via TGF-β/EMT signaling pathway in human non-small-cell lung cancer.

Journal: Cell biology international

Published: July 15, 2020

A detrimental mutation on USP40 unlocks the tumorigenesis in a rare case of lung cancer.

A detrimental mutation on USP40 unlocks the tumorigenesis in a rare case of lung cancer.

Journal: International journal of clinical and experimental pathology

Published: October 21, 2018

Rituximab effectively reverses Tyrosine kinase inhibitors (TKIs) resistance through inhibiting the accumulation of rictor on mitochondria-associated ER-membrane (MAM).

Rituximab effectively reverses Tyrosine kinase inhibitors (TKIs) resistance through inhibiting the accumulation of rictor on mitochondria-associated ER-membrane (MAM).

Journal: Cancer biomarkers : section A of Disease markers

Published: September 27, 2017

Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response.

Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response.

Journal: OncoTargets and therapy

Published: May 13, 2017

Probability of cancer in high-risk patients predicted by the protein-based lung cancer biomarker panel in China: LCBP study.

Probability of cancer in high-risk patients predicted by the protein-based lung cancer biomarker panel in China: LCBP study.

Journal: Cancer

Published: April 06, 2017

Significance of NLDA, the commixed index of inflammation, immune responses, hemostasis, and nutrition, for predicting metastatic non-small cell lung cancer prognosis and metastases.

Significance of NLDA, the commixed index of inflammation, immune responses, hemostasis, and nutrition, for predicting metastatic non-small cell lung cancer prognosis and metastases.

Journal: Oncotarget

Published: November 02, 2016

Pulmonary enteric adenocarcinoma with pancreatic metastasis: A case report.

Pulmonary enteric adenocarcinoma with pancreatic metastasis: A case report.

Journal: Oncology letters

Published: December 18, 2015

Posttranslational modifications of FOXO1 regulate epidermal growth factor receptor tyrosine kinase inhibitor resistance for non-small cell lung cancer cells.

Posttranslational modifications of FOXO1 regulate epidermal growth factor receptor tyrosine kinase inhibitor resistance for non-small cell lung cancer cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: December 13, 2014

RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib.

RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib.

Journal: International journal of clinical and experimental pathology

Published: June 20, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026